238 related articles for article (PubMed ID: 22638807)
1. Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer.
Kim S; Jung WH; Koo JS
Tumour Biol; 2012 Oct; 33(5):1681-94. PubMed ID: 22638807
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers.
Choi J; Jung WH; Koo JS
Histol Histopathol; 2012 Nov; 27(11):1481-93. PubMed ID: 23018247
[TBL] [Abstract][Full Text] [Related]
3. Metabolic phenotypes in triple-negative breast cancer.
Kim S; Kim DH; Jung WH; Koo JS
Tumour Biol; 2013 Jun; 34(3):1699-712. PubMed ID: 23443971
[TBL] [Abstract][Full Text] [Related]
4. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.
Choi J; Jung W; Koo JS
Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379
[TBL] [Abstract][Full Text] [Related]
5. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
Tang D; Xu S; Zhang Q; Zhao W
Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
[TBL] [Abstract][Full Text] [Related]
6. Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues.
Noh S; Kim DH; Jung WH; Koo JS
Tumour Biol; 2014 May; 35(5):4457-68. PubMed ID: 24390667
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.
He J; Peng R; Yuan Z; Wang S; Peng J; Lin G; Jiang X; Qin T
Med Oncol; 2012 Jun; 29(2):406-10. PubMed ID: 21264529
[TBL] [Abstract][Full Text] [Related]
8. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
9. Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.
Choi J; Kim DH; Jung WH; Koo JS
Breast Cancer Res; 2013; 15(5):R78. PubMed ID: 24020991
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
[TBL] [Abstract][Full Text] [Related]
11. Expression of autophagy-related proteins according to androgen receptor and HER-2 status in estrogen receptor-negative breast cancer.
Kim JY; Jung WH; Koo JS
PLoS One; 2014; 9(8):e105666. PubMed ID: 25140630
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
[TBL] [Abstract][Full Text] [Related]
13. Vimentin as a poor prognostic factor for triple-negative breast cancer.
Yamashita N; Tokunaga E; Kitao H; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Aishima S; Morita M; Maehara Y
J Cancer Res Clin Oncol; 2013 May; 139(5):739-46. PubMed ID: 23354842
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell metabolism-related genes in different molecular subtypes of triple-negative breast cancer.
Jeon HM; Kim DH; Jung WH; Koo JS
Tumori; 2013; 99(4):555-64. PubMed ID: 24326847
[TBL] [Abstract][Full Text] [Related]
15. EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray.
Liu D; He J; Yuan Z; Wang S; Peng R; Shi Y; Teng X; Qin T
Med Oncol; 2012 Jun; 29(2):401-5. PubMed ID: 21264531
[TBL] [Abstract][Full Text] [Related]
16. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
[TBL] [Abstract][Full Text] [Related]
18. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q
Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancer.
Min Kim H; Kim SK; Jung WH; Koo JS
Tumour Biol; 2015 Feb; 36(2):1207-12. PubMed ID: 25344213
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer.
Kim S; Moon BI; Lim W; Park S; Cho MS; Sung SH
Hum Pathol; 2016 Sep; 55():190-5. PubMed ID: 27184484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
